Patient-Reported Outcome Version of the Common Criteria for Adverse Events

Active, not recruitingOBSERVATIONAL
Enrollment

837

Participants

Timeline

Start Date

December 16, 2019

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
SurvivorshipCancer
Interventions
OTHER

Childhood Cancer Survivors (CCSS)

To use the PRO-CTCAE-SCC (beta version) to identify symptomatic adverse event (AEs) that are prevalent and clinically meaningful in adult survivors of childhood cancer vs. non-cancer controls, and to create symptomatic AE items that are not included in the current PRO-CTCAE for adult survivors of childhood cancer.

OTHER

SJLIFE

To use the current PRO-CTCAE to conduct a symptom content creation process for the PRO-CTCAE-SCC by identifying clinically meaningful symptomatic AEs for adult survivors of childhood cancer, to create symptomatic AE items not included in the current PRO-CTCAE, and to perform comprehensive medical evaluation, physical performance evaluation, and neurocognitive evaluation to clinically validate the PRO-CTCAE-SCC.

OTHER

Community non-cancer control

To use the PRO-CTCAE-SCC (beta version) to identify symptomatic adverse event (AEs) that are prevalent and clinically meaningful in non-cancer controls vs. adult survivors of childhood cancer, and to create symptomatic AE items that are not included in the current PRO-CTCAE for adult survivors of childhood cancer.

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

St. Jude Children's Research Hospital

OTHER

NCT04050072 - Patient-Reported Outcome Version of the Common Criteria for Adverse Events | Biotech Hunter | Biotech Hunter